Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01011101 · ClinicalTrials.gov registry record
Internal Monitoring of Eye Movement in Schizophrenia
A clinical trial, sponsored by National Eye Institute (NEI).
- Terminated
- Registry status
- 2
- Enrollment target
NCT01011101 is a clinical trial that was terminated before completion, run by National Eye Institute (NEI). The registered enrollment target is 2 participants.
The verdict
NCT01011101 was terminated before completion, sponsored by National Eye Institute (NEI).
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
Background: * Researchers are studying how humans are able to move our eyes to a remembered region even when the target has disappeared. The ability to do this suggests that the brain can keep track of where the eyes have looked, without an external target for continued reference. This is called corollary discharge. * Other research has indicated that patients with schizophrenia might have difficulty monitoring their eye movements. The corollary discharge process may be defective in patients with schizophrenia, and perhaps delayed in time. Researchers have developed a test to examine this possibility in the hope of learning more about schizophrenia and eye movement. Objectives: \- To assess whether there is a defect in internal monitoring of eye movements in patients with schizophrenia. Eligibility: * Individuals over 18 years of age who are able to give informed consent and are able to concentrate on a 20-minute task that involves following projected targets and moving their eyes to remembered locations. * Individuals with schizophrenia will be recruited from an ongoing NIH protocol studying schizophrenia. * In addition healthy will be recruited for this protocol. Design: * Researchers will check participants' vision in each eye, and ask them to sit at a machine that measures eye movement in order to complete research tasks. Researchers will monitor participants ability to complete these tasks. * The first task involves simply following a target that jumps to different parts of the screen. * The second is a 2-step task, in which a participant is asked to look at two separate light targets and then look at the remembered target positions when the lights are off. * This protocol does not provide treatment. Participants will remain under the care of their own physicians during participation in this protocol.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-11-02 |
| Est. Completion | 2016-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01011101
The ClinicalTrials.gov registry entry for NCT01011101 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Eye Institute (NEI), which has 221 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01011101 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01011101 about?
NCT01011101 is a clinical study titled "Internal Monitoring of Eye Movement in Schizophrenia". Background: * Researchers are studying how humans are able to move our eyes to a remembered region even when the target has disappeared. The ability to do this suggests that the brain can keep track of where the eyes have looked, without an external target for continued reference. This is called co...
What is the current status of trial NCT01011101?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2009-11-02. Estimated completion is 2016-08-16.
Who is sponsoring clinical trial NCT01011101?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.